Sarah Butt
@sarahbutt.bsky.social
210 followers
73 following
40 posts
Systems thinker. Student of complexity. “Like a moth to the incident flame”. Normally accompanied by 🦮 (she/her)
Posts
Media
Videos
Starter Packs
Sarah Butt
@sarahbutt.bsky.social
· Aug 18
Reposted by Sarah Butt
Reposted by Sarah Butt
Sarah Butt
@sarahbutt.bsky.social
· Jun 24
Reposted by Sarah Butt
Dr. Cat Hicks
@grimalkina.bsky.social
· Jun 23
To be sure, the pathway to FDA approval for elamipretide has been challenging.
Because MLS and related conditions are so rare, the patient population is tiny.
That makes it extremely difficult to conduct robust, controlled clinical trials—the kind the FDA usually requires for approval.
Because MLS and related conditions are so rare, the patient population is tiny.
That makes it extremely difficult to conduct robust, controlled clinical trials—the kind the FDA usually requires for approval.
Sarah Butt
@sarahbutt.bsky.social
· Jun 23
Sarah Butt
@sarahbutt.bsky.social
· Jun 23
Sarah Butt
@sarahbutt.bsky.social
· Jun 23
Sarah Butt
@sarahbutt.bsky.social
· Jun 17
Sarah Butt
@sarahbutt.bsky.social
· Jun 16
Sarah Butt
@sarahbutt.bsky.social
· Jun 16
Sarah Butt
@sarahbutt.bsky.social
· Jun 14
Sarah Butt
@sarahbutt.bsky.social
· Jun 8
Sarah Butt
@sarahbutt.bsky.social
· Jun 6
Reposted by Sarah Butt
Sarah Butt
@sarahbutt.bsky.social
· Jun 5
Sarah Butt
@sarahbutt.bsky.social
· Jun 3
Sarah Butt
@sarahbutt.bsky.social
· May 30
Sarah Butt
@sarahbutt.bsky.social
· May 28
Reposted by Sarah Butt
Sarah Butt
@sarahbutt.bsky.social
· May 27
Sarah Butt
@sarahbutt.bsky.social
· May 27
Reposted by Sarah Butt